NCT02453334 2021-05-11
IRON CLAD
American Regent, Inc.
Phase 3 Completed
Clinical Trials
4 trialsNCT02125344 2017-07-13
A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto)
GBG Forschungs GmbH
Phase 3 Completed
NCT01725789 2016-12-16
Ferinject® Assessment In GastRectomy Patients With Acute Isovolemic Anemia (FAIRY)
National Cancer Center, Korea
Phase 3 Completed
NCT01101399 2013-12-18
FID-CHEMO
Vifor Pharma
Phase 3 Completed